Target intelligence / Profile preview

Hemagglutinin protein, H3 subtype (HA (H3))

Target
HA (H3)
Molecular classification
Glycoprotein, Viral envelope protein, Class I fusion protein
01

Overview

The Hemagglutinin protein, H3 subtype (HA H3) is a homotrimeric glycoprotein on the surface of influenza A viruses, specifically the H3N2 strain like A/Aichi/2/1968, functioning as both a receptor-binding and membrane fusion protein essential for viral entry into host cells. It binds sialic acid receptors on respiratory epithelial cells via its HA1 subdomain, facilitating viral attachment, and undergoes pH-dependent conformational changes in endosomes to expose a fusion peptide in the HA2 subdomain, driving fusion of viral and host membranes to release viral RNA. Structurally, HA H3 features a membrane-distal receptor-binding site, vestigial esterase subdomain, fusion subdomain with alpha-helical coiled-coil, and membrane anchor, organized into HA1 and HA2 after proteolytic cleavage of precursor HA0. As part of 16 HA subtypes grouped phylogenetically, H3 belongs to Group 2 clade, with subtype-specific receptor preferences like alpha-2,6-linked sialic acids in human-adapted strains. In disease, HA H3 drives influenza infections, prompting annual strain-specific vaccines and antibody responses targeting its variable head or conserved stalk for broader protection, though no direct small-molecule drugs target it clinically.

Other names
HAinfluenza A hemagglutinin H3H3 hemagglutinin
02

Biological functions

Receptor bindingMembrane fusionViral attachmentViral entry
03

Disease associations

Infection

Beyond the preview

Go deeper on Hemagglutinin protein, H3 subtype (HA (H3)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemagglutinin protein, H3 subtype (HA (H3)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call